Efavirenz-Emtricitabin-Tenofovir-Mepha 600 mg, 200 mg, 245 mg, Filmtabletten - 30 Swissmedic Key 66217001 Registration Holder Mepha Pharma AG Name Efavirenz-Emtricitabin-Tenofovir-Mepha 600 mg, 200 mg, 245 mg, Filmtabletten Date of registration 18.07.2017 Original/Generic Generic Introduction of Sequence 18.07.2017 ATC-Classification Emtricitabine, Tenofovir Disoproxil and Efavirenz (J05AR06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.03. Show package size 30 Index Therapeuticus (Swissmedic) 08.03. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 526.02 Limitation No Deductible 10 % Consumer price 588.50 Feedback FB GTIN 7680662170018 Medication Code Synthetika Pharmacode Disponibility
Composition efavirenzum 600 mg, emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili phosphas, cellulosum microcristallinum, carmellosum natricum conexum, mannitolum, hydroxypropylcellulosum, poloxamerum 407, crospovidonum, hypromellosum, hydroxypropylcellulosum substitutum humile, oleum vegetabile hydrogenatum, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 120, pro compresso obducto corresp. natrium 7.23 mg. Packungsbestandteile Galenic Form Active Agent Dose Efavirenz 600 mg Emtricitabine 200 mg Tenofovir Disoproxil 245 mg
BAG: Active Agent Dose Efavirenz 600 mg Emtricitabine 200 mg Tenofovir Disoproxil 245 mg
Inactive agents Dose additional_information color. color. Hypromellosum Macrogol 3350 Mannitol Poloxamer 407 Überzug Talcum
Source Data was imported : 06.10.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
